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ABSTRACT
Porphyria induced by the fluorochrome, diethyl 1, 4-dihydro-2 ,4, 6-trimethyl py-
ridine-3 ,5-dicarboxylate (DDC) has been studied in laboratory rats and the factors
determining the pattern of porphyrin excretion have been assessed. Definitive studies
demonstrating specific photosensitivity of the skin in the porphyric rats have been
carried out.
It has been established that the magnitude of porphyrin excretion as well as the type
of porphyric pattern is dosage dependent. Increased fecal protoporphyrin output can
occur without other evidence of porphyria at a low dosage level. As the drug dosage is
increased, fecal and urinary coproporphyrin and finally urinary uroporphyrin Values
are additionally increased. These changes in porphyrin output have been explained on
the current theory that DDC inhibits the incorporation of protoporphyrin into heme
and the production of heme compounds so that by a positive feedback mechanism ALA
synthetase is activated and excess urinary copro and uroporphyrin excretion occurs.
The collidine derivative was well tolerated by animals receiving a conventional rat
diet ad libitum, but in animals on purified diets a state of chronic nutrient deprivation
precipitated acute toxicity. Toxic symptoms, associated with DDC intake at a high
dosage level, included constipation, icterus, oliguria and premature death.
The primary hepatic lesion of DDC-induced porphyria consisted in biliary hyper-
plasia with a surrounding mononuclear infiltrate. Discrete aggregation of protoporphyrin
within the bile ducts and in the periductal inflammatory cells was localized by polariza-
tion and fluorescence microscopy. At autopsy the animals exhibiting toxic symptoms
showed massive hepatic necrosis and renal tubular damage.
In 1959, Solomon and Figge (1) demon-
strated that the fluorochrome, diethyl 1,4-
dihydro-2 ,4,6-trimethylpyridine-3 ,5-dicarbox -
ylate (DDC) was a potent porphyrogenic
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agent. When this chemical was fed to mice, a
disturbance of porphyrin metabolism resulted,
which was characterized by a marked increase
in hepatic proto and coproporphyrin as well as
deposition of protoporphyrin and much smaller
amounts of uroporphyrin between the renal
cortex and pelvis. In the guinea pig oral DDC,
given for seven days, produced high levels of
urinary coproporphyrins, but only trace
amounts of porphobilinogen. Later studies by
these authors showed that the porphyrogenic
effects of DDC were not shared by its oxidation
products (2). These results have in general been
confirmed by other workers, though there has
been controversy about their interpretation.
While Dc Matteis and Prior concluded that the
experimental hepatic porphyria induced by
DDC was similar to that induced by drugs of
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the Sedormid group (3), several investigators
have shown that DDC and chemically related
drugs cause a more persistent block in heme
and heme compound formation, resulting in
massive accumulation of protoporphyrin in the
liver (4, 5).
The data presented in this communication
pertain to studies of DDC-induced porphyria
in the laboratory rat. The primary aim has been
to evaluate whether the laboratory rat is a
suitable experimental animal model for use in
screening drugs or industrial chemicals for
porphyrogenic properties. Relationships of dos-
age level to porphyria induction, the contribu-
tion ol endogeneous porphyrins from the
Harderian glands to porphyrin excretion and
the association between porphyria and chemi-
cal toxicity have been studied.
Another objective has been to study the re-
lation of porphyria induction to dietary depri-
vation. The epidemic of porphyria cutanea
tarda in rural populations of Southeastern
Turkey, due to ingestion of seed wheat treated
with hexachlorobenzene, occurred at a time of
relative famine (6). Numerous publications
have stressed that the disease was most severe
in growing children (7, 8, 9). We have there-
fore studied the effects of caloric restriction as
well as protein deprivation on young rats re-
ceiving porphyrogenic agents. This research has
been supplemented by photobiological studies
as an index of the severity of the porphyria.
Here we report the effects of DDC; results of a
similar study with hexachlorobenzene will be
reported later.
MATERIAL AND METHODS
Drug and drug dosage. DDC, obtained from
Eastman Kodak, was recrystallized from hot
ethanol and the yellow impurity removed by
washing the crystals on a Buchner funnel with 3N
HC1, followed by distilled water. The crystals
were dried, under reduced pressure, in a dessicator.
The pure compound was suspended in Arachis oil
at a concentration of 80 mg/mI, and given by
gastric intubation with a syringe attached to a
blunt-ended metal needle. Three dosage levels of
DDC were used, viz: 80 mg, 200 mg and 400 mg/kg
body weight. Arachis oil alone was given to control
animals in comparable amounts to that given to
the experimental animals.
Animals. Male Wistar albino rats were used in
these studies. The starting weights of rats on the
conventional rat chow diets varied between 200
and 350 gm and those on the purified diets be-
tween 105 and 168 gins. The animals were in-
dividually housed in wire bottom "holding" cages
and transferred for porphyrin determinations to
special cages that permitted complete separation
of urine and feces. Metabolic collections were
made Over 48 hour periods.
Diets. The rats were fed a pelleted rat chow
(MRC 41B) ad libitum except in the experiments
designed to show the effect of protein depletion
on the induction of porphyria (Table IA and TB).
In these nutritional studies the animals were
divided into two groups and pair fed purified diets
so that the intake of the rats on the "high protein"
TABLE IA
Composition of pelleted rat chow MRC 41B
%
Wheat 47.0
Sussex ground oats 40.0
Fish meal (66% protein) 8.0
Dried skim milk 3.0
Dried yeast (unextracted) 1.0
Salt 1.0
100.0
A vitamin supplement is added at 2.5 lbs/ton
which supplies oil and water soluble vitamins in
adequate quantities to meet rat requirements.
Molasses (5%) is added to the dry diet to bind
ingredients.
TABLE TB
Composition of purified rat diets
Low protein High protein
Casein 8.0 25.0
Corn oil 12.6 5.0
Corn starch 55.0 55.0
Choline 0.3 0.3
Salt mix 4.0 4.0
Fat soluble vitamins" 1.0 1.0
B vitamin mix' 2.0 2.0
Cellulose (Alphacel) 17.1 7.7
100.0% 100.0%
o Salt mix 11MW., Nutritional Biochemicals,
see ref. 10.
b Fat soluble vitamin mix: Vitamin A acetate
62.0 mg., vitamin D 0.9 mg., a-tocopherol 1000.0
mg., corn oil to 200 gm.
'B vitamin mix: Thiamine 0.4 gm., pyridoxine
0.4 gm., riboflavin 0.8 gm., Ca pantothenate 4.0
gm., niacin 4.0 gm., inositol 20.0 gin., menadione
1.0 gm., folic acid 0.2 gm., biotin/Bi, (3 mg/20 mg)
10.0 gm. cerelose to 2 kg.
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diet was restricted to that of the animals on the
"low protein" diet. The diets of the two animal
groups were made isocaloric by substitution of
corn oil in the diet of the protein depleted ani-
mals.
Surgical procedures. Removal of the Harderian
glands in selected rats anesthetized with Nembutal
was carried out by dissection under Wood's light.
Combined wet weights of the glands were measured
immediately after removal. The rats were returned
to the holding cages after this procedure until com-
plete recovery had taken place as determined by
food consumption and normal activity.
Biochemical studies. Extraction and isolation of
urinary and fecal porphyrins was carried out using
Rimington's method (11). Harderian gland por-
phyrins were extracted according to the method of
Schwartz (12). Spectrophotometric measurement
of individual porphyrins was performed using
either the Hilger Uvispek or the Beckman flU
Spectrophotometcr.Qualitative determination of urinary bilirubin
was made using a commercially prepared diazo
reagent. (Bili-Tcst Tablets—a Scientific Product,
Evanston, Illinois).
Photobiological studies. Irradiations were made
using a high intensity water-prism monochromator
with a 2 K.W. high pressure quartz xenon arc
source (13). Wave length calibration of the mono-
chromator was carried out with a low power, high
pressure polykymatic quartz mercury vapor arc
before each test irradiation. For monochromatic
irradiations at wave length 420 nm or below, a
W.G.3 Schott absorption ifiter was inserted in the
optical path of the monochromator to remove any
scattered U.V. below 320 nm. For longer wave
lengths in the visible spectrum a G.G. 475 Schott
filter was used.
Measurements of the irradiance at the exit slit
of the monochromator ware made with a cali-
brated low vacuum thermopile (HUger F.T. 17)
with 5i02 window. All measurements should, how-
ever, be taken as approximate and relative rather
than absolute.
The irradiations of the animals were made on
the shaved flank skin on which the sites to be
irradiated had bean marked out in such a way to
avoid overlap of reactions. The animals were held
firmly in a position which brought the marked
area into close contact with the exit slit. No skin
site was irradiated more than once.
The first few animals were irradiated with
monochromatic light at 400 nm to assess (a) if the
animals would react at all to this wave length, and
(b) to observe the sequence of reactions taking
place at the irradiated sites.
In the preliminary experiments it was found
that animals became photosensitive to 400 nm after
7 to 12 doses of DDC and would react to 2700
mW. sec/cm2 or less of this monochromatic light.
In later experiments therefore all animals were
routinely irradiated after 10 doses of DDC using
400, 350, 380, 420, 500, 600 and 700 nm wave
bands and multiple exposures with varying dos-
ages of light in order to determine the "minimal
dose for response" (MDR) at each of these wave
lengths. A minimum of 5 animals were used for
each wave length. Five normal rats, who were not
given DDC, served as controls and were irradiated
in a like manner to determine the MDR. These
animals were the same in which porphyrin excre-
tion values were obtained.
Early reactions were read by "blueing" the skin
with an intravenous or intraperitoneal injection
of 3 ml of Coomassie Blue solution. These injec-
tions were made immediately after the end of an
exposure and the site of irradiation inspected
pcridocially up to 48 hours. After 48 hours reac-
tions were assessed visually without use of Coomas-
sic Blue.
The absorption spectrum of DDC was deter-
mined with a recording spcctrophotometer (Uni-
cam SP 800) (Fig. 1).
Pathology techniques. At the end of each ex-
periment the animals were sacrificed by decapita-
tion. The hair, skin and teeth as well as the viscera
were examined under Wood's light for evidence of
gross porphyrin fluorescence. Histological sections
were cut from paraffin blocks of the livers, kidneys
and lungs. Sections were stained with hcmatoxylin
and cosin for routine light microscopy. Polariza-
tion optical examination and fluorescence micros-
copy of unstained sections was carried out.
RESULTS
Drug dosage level. Alterations in porphyrin
excretion, induced by DDC, varied with the
dose (Table II). Elevation of fecal protopor-
phyrin excretion followed initiation of DDC ad-
ministration, even at the lowest dosage em-
ployed, viz., 80 mg/kg body weight. In the rats
fed ad libitum on rat chow, this was accom-
panied by a moderate increase in fecal copra-
porphyrin excretion and small increases in the
excretion of urinary copro and uroporphyrin.
At the higher dosage level, viz., 400 mg/kg body
weight, the same pattern of change in porphy-
rin excretion occurred, but the level of por-
phyrins in the feces and in the urine was higher.
Substantially different gains in fecal protopor-
phyrin excretion were found from rat to rat.
Duration of DDE? administration. Chronic
administration of DDE? caused a decrease in
fecal porphyrin and an increase in urinary por-
phyrin excretion in some of the experimental
animals. Analysis of the data showed that
these trends were not significant for tbe rat
groups as a whole and no inverse relationsbip
between fecal and urinary porphyrin levels was
established (Table III).
Effect of Harderian gland ablation. Two rats
were subjected to Harderian gland excision
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wavelength In nm.
Fie. 1. Absorption spectrum of DIJC.The porphyrogenic agent was dissolved in ethanol
to give a 1.87 x 10° molar solution. Measurements were made on the Unicam SP 800.
TABLE II
Changes in porphyrin excretion in rats following DDC administration
(Data collected from rats fed conventional rat diet ad libitum)
Group No. rats Wt. gm.Mean S.D. DDC dosagemg/Kg
Urinary porphyrins Feral porphyrins
pg/24 hrs. jig/gm. dry wt.
(mean values) (mean values)
Copro Uro Copro Proto
A
B
3
11
233 14
314 40
0
80
0
400
1.93 0.11
5.10 0.36
9.50 0.51
32.85 5.03
1.60
12.07
8.75
37.89
27.03
84.59
38.94
328.98
Post-DDC porphyrin values were obtained from composite data of all metabolic collections made
from 10—20 days after drug initiation.
Statistical evaluation of group A was precluded by limited data available.
In group B very highly significant post-DDC increases in fecal prot.oporphyrin (t = 4.04 P < 0.005),
fecal coproporphyrin (t = 5.47 P < 0.001), urinary coproporphyrin (t = 4.69 P < 0.001) and urinary
uroporphyrin (t 4.97 P < 0.001).
prior to DDC administration. After recovery
from this procedure they showed marked reduc-
tion in I ecal protoporphyrin output (Table
IV). When DDC was given to these animals at
a level of 80 mg/kg body weight, one showed
only moderate increases in fecal protoporphy-
nfl output, while the other displayed the mas-
sive increase in protoporphyrin excretion,
which was characteristic of other animals fed
the drug at this dosage. A possible explanation
for the difference was found at autopsy, for
under Wood's light the Harderian gland abla-
tion was complete in the former rat, whilst in
the latter there were remnants in situ.
Dietary effects. The effect of DDC dosage
level on porphyrin excretion was clearer in
1.10
z
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TABLE III
Porphyrin excretion of rats on chronic DDC intake
Mean and range of values in longitudinal study of 14 animals on conventional diet receiving DDC at
a dosage level of 400 mg/Kg. The data refer to rats used in the photobiological studies (Table 7).
n = number of metabolic collections.
Duration
oIDDC
intake (days)
a
Urinary porphyrins
pg/24 hrs.
Fecal porphyrins
g/gm dry wt.
Copro Urn Copro Proto
0 14 9.50
(0.63—35.20)
0.62
(0.22—1.58)
8.44
(2.72—13.63)
37.56
(16.50—63.19)
3 4 34.33
(4.60—99.50)
2.12
(0.54—4.95)
68.19
(35.47—94.60)
640.33
(377.60—853.00)
8 4 40.38
(15.40—54.80)
4.23
(1.70—7.07)
42.71
(21.74—64.58)
307.09
(128.06—48480)
11 2 21.12
(11.19—31.04)
1.35
(0.16—2.54)
37.34
(36.79—37.88)
417.40
(359.60—475.20)
13 4 34.83
(28.70—51.50)
6.87
(4.70—10.03)
40.26
(27.13—55.20)
387.69
(213.56—539.90)
15 2 19.44
(16.62—22.25)
3.02
(2.79—3.25)
64.15
(61.20—67.10)
374.89
(257.38—492.40)
17 2 40.81
(23.07—58.54)
6.11
(3.74—8.48)
18.85
(16.64—21.05)
180.54
(142.48—218.60)
18 4 39.46
(20.44—67.50)
5.49
(1.97—12.10)
49.63
(38.50—60.70)
373.13
(190.40—468.30)
27 3 22.56
(19.14—25.35)
1.32
(0.81—1.61)
72.12
(43.97—114.20)
348.00
(283.70—457.40)
rats fed purified diets (Table V). On a daily
intake of the drug of 80 mg/kg the only sig-
nificant change in porphyrin excretion, even
after 10 days, was an elevation of fecal proto-
porphyrin excretion. The gains in fecal proto-
porphyrin excretion were not significantly
higher in the rats on a high protein diet at this
dosage level of the drug. At 200 mg/kg the mas-
sive gains in fecal protoporphyrin content were
similar in rats on high and low protein intake.
Changes in fecal coproporphyrin output were
not significant (P > 0.05). A small but signifi-
cant rise in urinary coproporphyrin output oc-
curred at this dose level, but the differences in
the urinary porphyrin output between the two
diet groups was not statistically significant.
Given DDC at a level of 400 mg/kg body
weight, elevation in fecal copro and protopor-
phyrin excretion was similar in both groups, but
urinary coproporphyrin and uroporphyrin ex-
cretion was significantly higher in the rats fed a
low protein diet.
Photosensitivity. The initial experiments de-
signed to study whether porphyria induced by
DDC resulted in photosensitivity showed that
most animals with the lower doses of DDC and
all animals with the higher dosage schedules
reacted to monochromatic irradiation at 400
rim. The degree of photosensitivity was more
marked with the higher dosages of DDC.
An evanescent, inconstant erythema appear-
ing immediately after the end of an exposure
and lasting for 3—5 minutes was noticed in the
more photosensitive animals. The erythematous
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area did not "blue" after an intravenous in-
jection of "Coomassie Blue."
The immediate erythema was followed by a
period of latency varying in duration between
1 to 4 hours, which in turn was followed by an
erythema with or without edema. This was
better visualized as "blueing" after parenteral
administration of "Coomassie Blue." After 18—
24 hours the positive reaction appeared as
"blueing" or "blanching" (pale center with
blueing at the periphery after an injection of
Coomassie Blue) and lasted for 36—48 hours
(Fig. 2a, b, c). Occasional lesions showed ec-
chymoses at the site of irradiation. No bulla or
flare was seen. In the less sensitive animals
these changes were followed by a brownish
pigmentation, scaling and atrophy, while in the
more sensitive animals after higher doses of
light these progressed to necrosis and ulcera-
tion which healed with scar formation.
The action spectroscopic studies showed that
none of the animals, normal or porphyric,
reacted at 600 and 700 nni even with the
highest doses of light employed in these experi-
ments. At 500 nm, 4 out of 5 animals; at 380
nm, 3 out of 5; and at 350 nm, 2 out of 5 ani-
mals reacted with blueing and at times edema.
In contrast to these results, all the animals
responded with blueing with or without edema
to monochromatic light at 400 nm and 420 nm.
Some of the rats also showed immediate ery-
thema. The MDR at 400 nm was less than at
420 nm. None of the control animals showed
any reaction with the highest doses of light em-
ployed (Table VII).
Evidence of DDC toxicity. Animals receiving
the conventional rat diet ad libitum tolerated
the drug at the highest dosage level, viz., 400
mg/Kg body weight, without evidence of acute
or chronic toxicity, except photosensitivity as-
sociated with the porphyria. However the
groups of animals which were pair fed on puri-
fied diets displayed marked signs of acute tox-
icity. This toxicity was much more severe in
the rats on the high protein intake and led to
premature death. All rats showed weight loss,
and in the rats on the high protein diet, signs
of combined hepatie and renal damage. The
rats on the 25% casein diet exhibited rapid
weight loss, jaundice, constipation and diminish-
ing urinary output within three days of receiv-
ing DDC at the dosage level 400 mg/Kg body
weight and animals died rapidly after these
symptoms were apparent (Table VI). Positive
correlation was obtained between weight gain
prior to DDC and weight loss after drug admin-
istration for animals on both high and low pro-
tein intake (Coefficient of Rank Correlation R
= 0.730). There was no evidence of neuro-
toxicity.
Pathology of DDC intoxication. At autopsy,
rats receiving DDC at all dosage levels showed
macroscopic porphyrin fluorescence of the
stomach and intestine. In addition, rats re-
ceiving the drug at a dosage level of 400 mg/kg
showed intense porphyrin fluorescence localized
to hemorrhages within the lungs.
The toxic animals had pathological signs of
massive liver necrosis and renal tubular necro-
sis with casts blocking the distal renal tubules
(Fig. 3a, b, c). All rats receiving DDC, regard-
less of the dosage level, showed a primary
TABLE IV
The effect of Harderian gland ablation on fecal
porphyrin content
Rat Status ofHarderian
gland
DDC dosage
Days
Fec,lPoPhYrins
Copro Proto
A
B
C
D
Intact
Ablation
Ablation
Intact
Ab1ation
Ablation
Intact
Intact
Intact
Intact
0
0
80
0
0
80
0
80
0
80
0
0
3
0
0
3
0
3
0
3
0.59
1.08
7.98
0.05
3.30
45.30
1.62
12.81
1.62
33.76
36.69
2.48
96.88
18.09
4.96
565.72
34.15
475.67
17.37
311.77
Ra
A
B
Total wet
wt. of glands
mg.
281.5
199.1
Harderian gland porphyrins,
sg/gm wet wt.
Coprob
132.78
63.28
Proto
161.69
78.56
Uro
0.91
0.21
Total
295.38
142.05
Remnants of Harderian glands found in rat B
at autopsy.
b Harderian coproporphyrin fraction may in-
clude tricarboxylic compounds.
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TABLE V
The effect of DDC dosage level on the porphyrin excretion of rats pair-fed on purified diets(Values represent mean increases or decreases in urinary and fecal porphyrins)
Group WtMean Rats
DDC
dosage
Urinary porphyrins
Duration g/24 hrs.
DDCadrnin.
Copro Uro
Fecal porphyrins
g/gm dry wt.
Copro Proto
L.P.
H.P.
L.P.
H.P.
L.P.
H.P.
148 9
156 17
187 9
200 22
185 27
202 10
4
4
4
4
8
8
80
80
200
200
400
400
10
10
3
3
3
3
—1.99
+0.39
+880
+5.95
+32.98
+8.35
—0.06
—0.27
—0.71
+1.00
+2.64
—4.96
—1.84
+2.47
+15.48
+23.49
+22.31
+13.49
+57.96
+148.81
+393.21
+493.61
+289.71
+283.64
Statistical evaluation of post DDC increases in porphyrin excretion
a) Dose dependent changes (both diet groups)
Significant or very highly significant increases in fecal protoporphyrin in rats on all dosage levels,
viz: 80mg/Kg t = 3.52 P < 0.01, 200 mg/Kg t = 2.35 P < 0.05, 400 mg/Kg t = 7.08 P < 0.001.
Significant increases in fecal coproporphyrin in rats on 400 mg/Kg dose only t = 2.82 P < 0.05.
Highly significant increases in urinary coproporphyrin excretion in rats receiving drug at higher
dosage levels, viz: 200 mg/Kg t = 5.23 P < 0.01, 400 mg/Kg t = 4.86 P < 0.005 (L.P.) and t = 5.52
P < 0.001 (H.P.).
Significant increases in urinary uroporphyrin excretion in rats on 400 mg/Kg dose only t = 2.82
P <0.05.
b) Low protein vs. high protein fed animals
Very highly significant differences in urinary porphyrin excretion in rats on 400 mg/Kg dose, viz:
copro t = 4.17 P < 0.001, uro t = 4.79 P < 0.001.
hepatic lesion consisting iii hyperplasia of the
bile ducts and duetules (Fig. 4a, b). Surround-
ing the bile ducts there was a mononuclear in-
filtrate consisting in histiocytes and lympho-
cytes. Localized deposition of protoporphyrin,
in crystal form, was present within the bile
ducts and within and between the cells of the
mononuclear infiltrate.* Hyaline degeneration
of the cells of the hepatic parenchyma and
necrosis amounting to complete loss of the nor-
* The identification of the crystalline deposits
in the liver as protoporphyrin has been established
in weanling pigs treated with DDC. In these ani-
mals the primary hepatic lesion is identical with
that found in the rats but birefringent crystalline
aggregates were also found in the bile. These ag-
gregates had the solubility and absorption char-
acteristics of protoporphyrin.
In a rat stud carried out subsequent to the
preparation of this paper, it was found that hepatic
protoporphyrin levels were elevated after 3 days
treatment with DDC at a dosage level of 400
mg/kg. Liver copro and uroporphyrin was not
significantly raised in this experiment.
mal liver structure was present in the rats with
severe acute toxicity. Massive hemorrhages
were present within the liver substances and
damage to the endothelial lining of the sinusoids
was obvious.
DISCUSSION
It appears that in evaluating the effect of a
chemical compound on hepatic porphyrin me-
tabolism factors imposed by the experimental
conditions have to be considered. Our studies
with DDC have shown that overt porphyrin-
uria is associated only with high dosage levels
of the compound. With lower dosages of DDC
there was greater variability in the pattern of
porphyrin excretion and the only uniform find-
ing in rats maintained under differing experi-
mental conditions was an increased fecal proto-
porphyrin output. It also appeared that if a
low dose rate of DDC was maintained over a
long period of time that there was a diminution
FIG. 2. Photosensitivity reactions in DDC-treated rats exposed to monochromatic light at
400 nm. Visualization of delayed cutaneous responses following i.v. injection of Coomassie
Blue, a) Erythema immediately after test exposure. b) Delayed erythema after 24 hours,
showing peripheral "blueing" and central blanching reaction. c) Edema reaction lasting from
24—72 hours after irradiation. In Fig. 2 a) and b) ecchymosis can be seen at the site of
irradiation.
407
S = sacrifice by decapitation.
of porphyrin output. Reduction of porphyro-
genie potency on chronic feeding may be re-
lated to a drug-induced detoxification mecha-
nism. Thus, to ascribe a particular pattern of
porphyrin excretion to a specific porphyrogenic
agent may he misleading, unless this is related
to the level and duration of intake.
The toxic properties of DDC primarily ef-
fect the liver and there has been no evidence
of neurotoxieity such as may he associated
with the administration of porphyrogenie
compounds like the halogenated benzenes (14,
15).
It was shown by Onisawa and Labbe that
after DDC administration, the livers of mice
were firm on palpation and dark red in color
(16). When DDC was given to the guinea pigs,
Graniek and [Jrata demonstrated the localiza-
tion of protoporphyrin within the hepatie
parenchyma by fluorescence microscopy (17).
These authors also showed that there were red
brown granules within the liver cells which to
polarized light appeared as triehite crosses. It
was suggested that these birefringent masses
consisted of crystalline needles of protoporphy-
rin in a rosette-like arrangement. Chronic
poisoning with DDC was shown to result in
cirrhosis. In the rat, toxicity to DDC is mani-
fested by anorexia, sudden loss of weight,
constipation, oliguria and jaundice. These symp-
toms are similar to those described by de
Matteis and Rimington in griseofulvin toxicity
(18). Both in the ease of griseofulvin and with
DDC, there is a premortal decrease in the
urinary excretion of pyrrole compounds. The
signs and symptoms of toxicity can be ex-
plained from the histological findings, though it
is somewhat difficult to isolate the toxic effects
of DDC on the liver from those due to deposi-
tion of porphyrin. The primary hepatie lesion
due to the eollidine derivative is deposition of
protoporpbyrin crystals in and around the bile
duets and duetules, and a periductular foreign
body reaction. The question arises whether
secondary necrosis of the hepatie parenehyma is
due to the collidine derivative is deposition of
tasis from duet blockage by crystalline porphy-
rin. Although Rimington (19) has stated that
diffuse hepatie poisons destroy the concen-
trating power of the liver cell, so that uptake of
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TABLE VI
Drug toxicity in rats receiving purified diets plus DDG at a dosage level of 400 mg/g
Rat
Diet
DurationType
Pre-DDC
wt. gain
Post-DDC
3 day
wt. losa
Duration
ot DnC
—. death
Prensortal evidence of toxicity
Conati-
patlona Icterusb Oliguria0
1
2
3
4
9
10
11
12
19
20
21
22
27
28
29
30
L P.
L.P.
L.P.
L.P.
L P.
L.P.
L.P.
L.P.
H.P.
H.P.
H.P.
H P.
H.P.
H.P.
H.P.
H.P.
2/12
2/12
2/12
2/12
3/12
3/12
3/12
3/12
2/12
2/12
2/12
2/12
3/12
3/12
3/12
3/12
67
66
77
61
—9
74
76
69
99
92
96
61
121
96
80
85
—18
—17
—13
—14
+7
—4
—15
—9
—25
—14
—18
—12
—21
—28
—16
—15
(daya)
13 (5)
40 (5)
40 (5)
40 (5)
3 (5)
3 (5)
3 (5)
3 (5)
5
4
4
13 (5)
3 (8)
3 (8)
3 (5)
3
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
a Constipation refers to absence of post-DDC fecal output.
h Icterus denotes positive test for urinary bile pigments.
a Oliguria defined as urinary output <4.0 ml/24 hrs.
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porphyrins is prevented and renal excretion
consequently occurs, this generalization is not
applicable without qualification to the case of
DDC. There has been no evidence of an inverse
relationship between the excretion of fecal and
urinary porphyrins. Rats, in the premortal
state, excrete no porphyrins from the large in-
testine. This however, is due to absolute con-
stipation and when the contents of the large
intestine are extracted, they are found to con-
tam massive amounts of protoporphyrin and
smaller amounts of coproporphyrin.
Decreased urinary excretion of porphyrms
prior to death can be explained on the basis of
the renal lesions which include necrosis of the
distal convoluted tubules as well as the collect-
ing tubules which are blocked by casts. It
may be assumed that renal tubular passage of
porphyrins is depressed by the kidney pathol-
ogy. At present it is not possible to decide
whether the renal lesions are due to direct
DDC toxicity or are secondary to the hepatic
changes. Porphyrin excretion can only be a
measure of porphyrin synthesis if the kidney
is intact and intestinal function within physio-
logical limits.
Tolerance for DDC is greatest in rats re-
ceiving a conventional rat chow diet ad
libitum. These animals received the collidine
derivative at a dosage level of 400 mg/kg body
weight without showing evidence of toxicity.
Among rats on purified diets, the rats which
were protein depleted tolerated the chemical
much better than those on a high protein in-
take. The simplest explanation of this rests on
the fact that the high protein group were main-
tained under conditions of relative caloric dep-
rivation in relation to their growth require-
ments, brought about by the technique of
pair-feeding. The premise that hepato-toxicity
of DDC is influenced by growth rate is supported
by the positive correlation between weight gain
prior to DDC and weight loss afterwards (see
Table VI). In a recent study, it was shown that
if a drug metabolite is more toxic than the
parent compound, then protein depletion ex-
ercises a protective effect because drug metabo-
lism in the liver is depressed (20). This prin-
ciple might also explain the effects observed
with DDC.
Normal coprophagy in the rat (21) limits
utilization of changes in fecal porphyrin output
is a measure of altered porphyrin metabolism.
TABLE VII
Relationship between wave length and minimal dose
for cutaneous response (MDR) in porphyric and
control rats exposed to monochromatic light*
Porphyric group Control group
1350
>2700
675
>2700
330
675
1350
2700
675
1350
2700
500 4
1
2700
>2700
5 >2700
600
700
5
5
>2700
>2700
5
5
>2700
>2700
* Values given in this table refer to rats fed
MRC 41B diet ad libitum. Porphyric animals had
received DDC (400 mg/kg) for 10 days.
In the present limited studies it has also been
demonstrated that the porphyrin secretion of
the Harderian gland, which is ingested by the
rat, contributes significantly to the fecal proto-
porphyrins, and this has indeed been suggested
by earlier studies (22).
It is difficult to classify the type of experi-
mental porphyria induced by DDC. Apparently
the type of porphyria produced is dependent
on the dosage level of the drug. At the higher
dosage level the pattern of porphyrin excretion
suggests the changes associated with so-called
symptomatic cutaneous porphyria (porphyria
cutanea tarda) - However on the lower dosage
levels, viz., 80 mg/Kg, the picture shows simi-
larity to the congenital erythropoietic protopor-
phyria occurring in man. Thus, there was mas-
sively increased fecal protoporphyrin excretion
and a liver pathology which has been associated
MDR
mWsec./
cm' rats
5
MDR
mW.
sec/cm'
>2700
Wave length
urn.
350
380
400
420
Cats
2
3
3
2
4
2
1
3
2
2
1
5 >2700
5 >2700
5 >2700
Fie. 3. Hepato-renal pathology in DDC-treated rat maintained on a high protein purified
diet. Animal sacrificed after 3 days of DDC administration (400 mg/kg). a) Low power view
of liver showing hepato-cellular necrosis, maximal around portal tracts (H and E >< 103).
b) High power view of liver showing individual cell necrosis, pyknotic nuclei and hyaline
bodies in the cytoplasm (H and E >< 387). c) High power view of kidney showing necrosis
of tubular epithelium and cast in situ. (H and E X 387).
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Pie. 4. Primary hepatic lesion of DDC-induced porphyria. The rat was maintained on a
high protein purified diet and received DIJC at a dose of 80 mg/kg for 53 days. a) High
power view of liver showing biliary hyperplasia and surrounding stromal infiltrate of histio-.
cytes and lymphocytes. Large pigment masses are situated within and between the bile
ductules. Both hepatocellular necrosis and regeneration can be seen in the liver parenchyma
(H and E X 300). b) High power view of liver under polarized light showing crystalline
deposits within a bile duct (X) and Maltese cross figures in the surrounding stroma (Y)
(H and E X 300). The birefringent material corresponds in location with the pigment masses
which showed characteristic porphyrin fluorescence.
with this form of porphyria (23). In the ab- phyrins after DDC administration to rats and
sence of erythrocyte porphyrin assays in our mice (24, 25).
studies, the localization of porphyrin fluores- It is known that DDC inhibits the incorpora-
cence to hemorrhages within the lungs may tion of protoporphyrin into heme (16). If it is
lend some support to this explanation. Further- assumed that heme is the normal repressor of
more, de Matteis noted raised erythrocyte por- ALA synthetase activity (26), then with dimin-
4 
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ished formation of this end-product, ALA syn-
thetase would be activated and this would re-
suit in the over-production of abnormal liver
porphyrins. Presumably with liver damage,
these porphyrins would be reabsorbed into the
circulation and eventually excreted in the
urine. This would explain the different patterns
of porphyrin excretion occurring in the rat
groups which were studied.
The present study, to our knowledge, is the
first successful attempt at delineating the ac-
tion spectrum for photosensitivity in porphyric
animals. These investigations showed that the
most reactive wave length in these animals was
400 nm. The reactivity at 420, 380 and 500 nm
was less marked than at 400 urn. The results are
in conformity with the results of action spec-
trum in human porphyric patients (27, 28, 29,
30), and correspond closely with the absorption
spectrum for porphyrins, thereby satisfying the
requisites of the Grotthus-Draper Law. Again
this action spectrum is quite unlike the spec-
trum for normal sunburn.
Because a few animals reacted to monochro-
matic light at 350 and 380 nm, the suggestion
has been retained that the photosensitivity
could in part be due to the direct effect of DDC
in the skin. However in view of the character-
istic evaluation of the skin changes, this seems
unlikely. These experimental studies lend
further support to the evidence already pre-
sented in humans (27, 30) concerning the role
of porphyrins in the production of photosensi-
tivity and would tend to negate the contention
of Blum (31) and Clare (32) that cutaneous
porphyrins play no part in the photosensitivity
of porphyria.
The pattern of the response observed on ir-
radiating the skin, with minor differences, is
similar to that seen in human subjects with
porphyria (30). Immediate erythema, delayed
erytherna with or without edema, scaling,
atrophy, ecchymoses, have all been observed
in human patients. The differences in time-
course of these reactions and the absence of
bullous lesions and flare, may possibly be be-
cause of species differences and differences in
the structure of skin. Again, the biphasic re-
sponse observed does not seem to be peculiar
to photosensitivity in porphyric rats, since
similar response has been reported in rats in
inflammation secondary to heat or U.V. ir-
radiation (33, 34). The inconsistency of the
immediate erythema is possibly related to the
degree of photosensitivity since only the more
photosensitive animals showed this.
The obvious cause for these photosensitive
reactions would seem to be the presence of in-
creased amounts of porphyrins in the skin.
While no attempt was made to determine the
porphyrin content of skin in this study, that
this may be elevated has been shown by
Pathak and Burnett (35) in porphyric pa-
tients and hexachlorobenzene-induced porphy-
nc rats.
The morphology of the photosensitivity re-
actions has been interpreted by Stratigos and
Magnus (36) and more recently by Hunter,
Bhutani and Magnus (37). It was shown that
the initial erythema is due to vaso-congestion of
the horizontal plexus of dermal capillaries, but
with the onset of edema, the microscopic view
of the congested vessels is obscured and this is
associated with pallor of the skin. In severe re-
actions, thrombi develop and the overlying
edema is absorbed very slowly. Thus pallor of
the reaction site after Coomassie Blue injection
is due to failure of the dye to enter the vessels
which are congested and thrombosed.
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